Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis

Jiao Feng(Tongji University), Chuanyong Guo(Tongji University)
Journal of Experimental & Clinical Cancer Research
January 30, 2020
Cited by 230


Related Papers